Another study focused on T2D used a combination of pancreatic cell expression data, chromatin accessibility, and network analysis methods to prioritize the gene RFX6 from GWAS results for the disease (Walker et al., 2023). This evidence concerns the gene RFX6 and type 2 diabetes mellitus.